KEW Group provides personalized oncology analysis services.
KEW is a genomic profiling company devoted to providing custom, CANCERPLEX® test-backed precision medicine therapeutic options to patients based on their tumor's specific genetic profile. KEW was founded in 2009 by Jeff Elton, Kathy Behrens WilseyKathy Behrens Wilsey and Raju Kucherlapati and is headquartered in Cambridge, Massachusetts.
KEW is a genomic profiling company devoted to providing custom, CANCERPLEX® test-backed precision medicine therapeutic options to patients based on their tumor's specific genetic profile. KEW was founded in 2009 by Jeff Elton, Kathy Behrens Wilsey and Raju KucherlapatiRaju Kucherlapati and is headquartered in Cambridge, Massachusetts.